Bioorganic and Medicinal Chemistry Letters p. 2253 - 2258 (1998)
Update date:2022-08-03
Topics:
Goulet, Mark T.
McAlpine, Shelli R.
Staruch, Mary Jo
Koprak, Samuel
Dumont, Francis J.
Cryan, John G.
Wiederrecht, Gregory J.
Rosa, Raymond
Wilusz, Mary Beth
Peterson, Laurence B.
Wyvratt, Matthew J.
Parsons, William H.
A series of C32-O-aralkyl ether derivatives of the FK-506 related macrolide ascomycin have been prepared based on an earlier reported C32-O- cinnamyl ether design. In the present study, the nature of the aryl tethering group was varied in an attempt to improve oral activity. An imidazol-2-yl- methyl tether was found to be superior among those investigated and has resulted in an ascomycin analog, L-733,725, with in vivo immunosuppressive activity comparable to FK-506 but with an improved therapeutic index.
View Morewebsite:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
puyang hongda shengdao new material co.,ltd.
Contact:+86-393- 4896278
Address:No.29 East Zhongyuan Road
Shanghai Massive Chemical Technology Co., Ltd.
website:http://www.massivechem.com/
Contact:+86 21 34943721
Address:Room 435, 4th floor, Building 9, No. 2568 Gudai Road,Minhang District, Shanghai,
Contact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
Doi:10.1021/jo020256i
(2002)Doi:10.1039/c4ra16760k
(2015)Doi:10.1021/jm9604078
(1996)Doi:10.1016/S1381-1169(99)00244-7
(2000)Doi:10.1016/S0040-4039(98)01553-6
(1998)Doi:10.1080/07328319908044614
(1999)
